Abstract:Background: Increasing evidence indicates that oxidative stress and interferon γ (IFNγ)-driven cellular immune responses are responsible for the pathogenesis of vitiligo. However, the connection between oxidative stress and the local production of IFNγ in early vitiligo remains unexplored. The aim of this study was to identify the mechanism underlying the production of IFNγ by mast cells and its impact on vitiligo pathogenesis. Methods: Skin specimens from the central, marginal, and perilesional skin areas of active vitiligo lesions were collected to characterize changes of mast cells, CD8+ T cells, and IFNγ-producing cells. Cell supernatants from hydrogen peroxide (H2O2)-treated keratinocytes (KCs) were harvested to measure levels of soluble stem cell factor (sSCF) and matrix metalloproteinase (MMP)-9. A murine vitiligo model was established using Mas-related G protein-coupled receptor-B2 (MrgB2, mouse ortholog of human MrgX2) conditional knockout (MrgB2-/-) mice to investigate IFNγ production and inflammatory cell infiltrations in tail skin following the challenge with tyrosinase-related protein (Tyrp)-2 180 peptide. Potential interactions between the Tyrp-2 180 peptide and MrgX2 were predicted using molecular docking. The siRNAs targeting MrgX2 and the calcineurin inhibitor FK506 were also used to examine the signaling pathways involved in mast cell activation. Results: IFNγ-producing mast cells were closely aligned with the recruitment of CD8+ T cells in the early phase of vitiligo skin. sSCF released by KCs through stress-enhanced MMP9-dependent proteolytic cleavage recruited mast cells into sites of inflamed skin (Perilesion vs. lesion, 13.00 ± 4.00/HPF vs. 26.60 ± 5.72/HPF, P <0.05). Moreover, IFNγ-producing mast cells were also observed in mouse tail skin following challenge with Tyrp-2 180 (0 h vs. 48 h post-recall, 0.00 ± 0.00/HPF vs. 3.80 ± 1.92/HPF, P <0.05). The IFNγ+ mast cell and CD8+ T cell counts were lower in the skin of MrgB2-/-mice than in those of wild-type mice (WT vs. KO 48 h post-recall, 4.20 ± 0.84/HPF vs. 0.80 ± 0.84/HPF, P <0.05). Conclusion: Mast cells activated by MrgX2 serve as a local IFNγ producer that bridges between innate and adaptive immune responses against MCs in early vitiligo. Targeting MrgX2-mediated mast cell activation may represent a new strategy for treating vitiligo.

Acceleration of Melanocyte Senescence by the Proinflammatory Cytokines IFNγ and TNFα Impairs the Repigmentation Response of Vitiligo Patients to Narrowband Ultraviolet B (NBUVB) Phototherapy

Intracellular virus sensor MDA5 exacerbates vitiligo by inducing the secretion of chemokines in keratinocytes under virus invasion

Increased Splicing of CXCR3 Isoform B (CXCR3B) by Impaired NRF2 Signaling Leads to Melanocyte Apoptosis in Active Vitiligo

1205 MIF-inhibition Ameliorates Vitiligo by Suppressing CD8+T Cell Activation and Proliferation

Repigmentation by combined narrow‑band ultraviolet B/adipose‑derived stem cell transplantation in the mouse model: Role of Nrf2/HO‑1‑mediated Ca2+ homeostasis

513 NLRP3-dependent Innate Cytokine IL-1β in Keratinocytes Promotes Immune Response of CD4 and CD8 T Cells in Vitiligo Patients

Evaluation of melanocyte stem cell population in vitiliginous skin pre- and post-narrow-band UVB phototherapy

Vitiligo non‐responding lesions to narrow band UVB have intriguing cellular and molecular abnormalities that may prevent epidermal repigmentation

MIF Inhibition Alleviates Vitiligo Progression by Suppressing CD8+ T Cell Activation and Proliferation

Targeting the Elevated IFN-γ in Vitiligo Patients by Human Anti- IFN-γ Monoclonal Antibody Hampers Direct Cytototoxicity in Melanocyte

Impact of Combined Phototherapy and Melanocyte Transplantation on Indicators of Vitiligo Activity

Novel Approaches to Vitiligo Treatment Via Modulation of Mtor and NF-κB Pathways in Human Skin Melanocytes

Involvement of interferon γ-producing mast cells in immune responses against melanocytes in vitiligo requires MrgX2 activation

The effects of NB-UVB on the hair follicle-derived neural crest stem cells differentiating into melanocyte lineage in vitro

Effects of immune microenvironment on the expression of CXCL10 in melanocytes of vitiligo

Melanocyte-keratinocyte cross-talk in vitiligo

Activated NLR family pyrin domain containing 3 (NLRP3) inflammasome in keratinocytes promotes cutaneous T-cell response in patients with vitiligo

Role of the P53‑trpm1/mir‑211‑mmp9 Axis in UVB‑induced Human Melanocyte Migration and Its Potential in Repigmentation.

Vitiligo: From Pathogenesis to Treatment

Narrow-band UVB irradiation stimulates the migration and functional development of vitiligo-IgG antibodies-treated pigment cells

NB-UVB promotes melanogenesis and cell proliferation through downregulating the expression of miRNA-25 in human melanocytes